KYKei Yoshida

Kei Yoshida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kei Yoshida has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of the clinical effects of intermittently scanned and real‐time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study

    by Tatsuhiko Urakami, Hiroki Terada, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Yasuko Shoji, Junichi Suzuki, Ichiro Morioka

    Aims/Introduction: The aim of the study was to compare two continuous glucose monitoring (CGM) systems, intermittently scanned CGM (isCGM) and real‐time CGM (rtCGM), to determine which system achieved better glycemic control in pediatric patients.Materials and Methods: We carried out a retrospective cohort study of children and adolescents with type 1 diabetes, and compared the time in range (70–180 mg/dL), time below range (180 mg/dL), and estimated glycated hemoglobin levels between patients on isCGM and rtCGM.Results: Of the 112 participants, 76 (67.9%) used isCGM and 36 (32.1%) used rtCGM for glycemic management. Patients on rtCGM had significantly greater time in range (57.7 ± 12.3% vs 52.3 ± 12.3%, P = 0.0368), and had significantly lower time below range (4.3 ± 2.7% vs 10.2% ± 5.4%, P < 0.001) than those on isCGM, but there was no significant difference in the time above range (37.4 ± 12.9% vs 38.0% ± 12.5%, P = 0.881) or the glycosylated hemoglobin A1c levels (7.4 ± 0.9% vs 7.5 ± 0.8%, P = 0.734) between the two groups.Conclusions: Pediatric patients with type 1 diabetes on rtCGM also showed more beneficial effects for increase of time in range, with a notable reduction of time below range compared with those on isCGM. Real‐time CGM might provide better glycemic control than isCGM in children with type 1 diabetes.


  • Open Access

    Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes

    by Tatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Junichi Suzuki, Ichiro Morioka

    Aims/Introduction: We examined the impact of scanning frequency with flash glucose monitoring on glycemic control in children and adolescents with type 1 diabetes.Materials and Methods: The study included 85 patients, aged 14.0 ± 0.5 years, with type 1 diabetes. The median time in the target glucose range (TIR) and glycosylated hemoglobin (HbA1c) values were 50.0 ± 1.4% and 7.5 ± 0.1%, respectively.Results: The median scanning frequency using flash glucose monitoring was 12.0 ± 0.4 times/day. Scanning frequency showed a significant positive correlation with TIR and an inverse correlation with HbA1c. Scanning frequency was identified to be the determinant of TIR and HbA1c by using multivariate analysis. The participants whose scanning frequency was 12 times/day were categorized as the high‐frequency group (n = 45). Patients in the high‐frequency group were more likely to be treated with insulin pumps compared with those in the low‐frequency group; however, this difference was not significant (21.3 vs 5.3%, P = 0.073). The high‐frequency group showed significantly greater TIR than the low‐frequency group (57 ± 1.6 vs 42 ± 1.7%, P = 0.002). Furthermore, the high‐frequency group showed significantly lower HbA1c levels than the low‐frequency group (6.8 ± 0.1 vs 8.0 ± 0.1%, P < 0.001).Conclusions: These findings showed that patients with a higher scanning frequency had better glycemic control, with greater TIRs and lower HbA1c levels, compared with those with a lower scanning frequency. Scanning frequency of >12 times/day might contribute to better glycemic outcomes in real‐world practice in children with type 1 diabetes.


  • Glucagon stimulation test as a possible predictor of residual β‐cell function

    by Kei Yoshida, Tatsuhiko Urakami, Ichiro Morioka

    Background: We aimed to investigate the significance of the C‐peptide levels on a glucagon stimulation test (GST) conducted soon after diagnosis as a predictive marker for residual β‐cell function over time in Japanese children with type 1 diabetes (TD1).Methods: We retrospectively enrolled 65 Japanese children (25 male, 40 female; age <16 years) with new‐onset TD1. A GST was conducted within 1 month of diagnosis, when glucose toxicity improved. One‐ to 2‐h postprandial serum C‐peptide values were measured at 0, 3, 6, 12, 24, 36, 60, and 120 months after diagnosis.Results: Receiver operating characteristic analysis showed that the cutoff values of peak serum C‐peptide levels used to predict the complete destruction of β‐cells at 3, 6, and 12 months after diagnosis were all 0.20 ng/mL (area under the curve [AUC] 0.867, 95% confidence interval [CI] 0.745–0.990; AUC 0.774, 95% CI 0.634–0.914; and AUC 0.804, 95% CI 0.695–0.914, respectively); the values at 24, 36, and 60 months were 0.69 ng/mL (AUC 0.828, 95% CI 0.721–0.936), 0.60 ng/mL (AUC 0.777, 95% CI 0.636–0.918), and 0.70 ng/mL (AUC 0.848, 95% CI 0.715–0.982), respectively. On multivariate analysis, peak serum C‐peptide level on a GST, diabetic ketoacidosis, age, and HbA1c level at diagnosis were associated with residual β‐cell function over time.Conclusions: Peak serum C‐peptide levels on a GST conducted soon after diagnosis in Japanese children with TD1 could predict the time to decrease in postprandial serum C‐peptide values to < 0.20 ng/mL.


  • Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring‐derived glycemic makers in children and adolescents with type 1 diabetes

    by Junichi Suzuki, Tatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Ichiro Morioka

    Background: We assessed the association between scanning frequency of flash glucose monitoring (FGM) and continuous glucose monitoring (CGM)‐derived glycemic markers in children and adolescents with type 1 diabetes.Methods: Subjects consisted of 85 children and adolescents with type 1 diabetes using FGM. We assessed the association between scanning frequencies of FGM‐ and CGM‐derived metrics: Time in range (TIR) (70‐180 mg/dL), time below range (TBR) (180 mg/dL), and other glycemic markers – laboratory‐measured HbA1c and CGM‐estimated glucose and HbA1c (eA1c) levels in the subjects.Results: The mean number of scans was 11.5 ± 3.5 (5–20) times per day, and scanning was most frequently conducted during a period of 18–24 h. Scanning frequency showed significant positive correlation with TIR (r = 0.719, P < 0.0001) and inverse correlation with time above range (r = −0.743, P < 0.0001), but did not correlate with TBR. There were also significant inverse correlations between scanning frequency and glucose, HbA1c, and eA1c levels (r = −0.765, −0.815, and −0.793, respectively, P < 0.0001).Conclusions: Frequent glucose testing with FGM decreased hyperglycemia with increased TIR, but did not reduce TBR. Coping with a rapid fall of glucose and unexpected hypoglycemia with more advanced technology might contribute to a reduction in TBR.


  • Open Access

    Case of type 2 diabetes possibly caused by excessive accumulation of visceral fat in a child born small‐for‐gestational age

    by Remi Kuwabara, Tatsuhiko Urakami, Kei Yoshida, Ichiro Morioka

    We encountered a 12‐year‐old boy with type 2 diabetes who was born small‐for‐gestational age. We described his clinical characteristics and a possible etiological factor for development of hyperglycemia. He developed well with sufficient nutrition and progressed to being overweight at 6 years‐of‐age as a result of a high‐calorie, high‐protein intake diet. He showed a diabetic pattern with a normal insulin response on an oral glucose tolerance test carried out with the urine glucose screening program at schools. He showed a large total fat area of 239.4 cm2; in particular, his visceral fat area was 103.0 cm2 with a high ratio of visceral fat area to subcutaneous fat area (0.76). The present case might show that insulin resistance, possibly as a result of accumulation of a great amount of visceral fat, might be attributed to the pathogenesis of type 2 diabetes in children born small‐for‐gestational age.


  • Open Access

    Juvenile case with the coexistence of maturity‐onset diabetes of the young 1 and later‐onset latent autoimmune diabetes in youth

    by Kei Yoshida, Tatsuhiko Urakami, Yusuke Mine, Remi Kuwabara, Ichiro Morioka

    We present the case of a 12‐year‐old Japanese girl, who was positive for markers of both maturity‐onset diabetes of the young and latent autoimmune diabetes in youth. She was initially diagnosed with maturity‐onset diabetes of the young 1 based on the molecular analysis, and she later developed an autoimmune response, leading to β‐cell‐associated antibody‐positive diabetes. She was treated with incretin‐associated drugs and maintained adequate glycemic control. Pathophysiologically, there was an overlap between the two different types of diabetes, because the hyperglycemia and β‐cell stress seen in non‐autoimmune diabetes can cause β‐cell autoimmunity over time.


  • Open Access

    Morphology-Based Analysis of Myoblasts for Prediction of Myotube Formation

    by Kiyoshi Ishikawa, Kei Yoshida, Kei Kanie, Kenji Omori, Ryuji Kato